Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2025 13:39 ET | Source: Spherix Global Insights

Specialists Eye Gazyva as a New Option for Lupus Nephritis, but ACR Guidelines Favor Benlysta and Lupkynis for Upfront Use, According to Spherix Global Insights

EXTON, PA, April 30, 2025 (GLOBE NEWSWIRE) -- The American College of Rheumatology’s (ACR) newly updated treatment guidelines for lupus nephritis (LN) have led specialists to reconsider their...
October 10, 2024 10:28 ET | Source: Spherix Global Insights

Roche/Genentech’s Gazyva Poised to Transform Lupus Nephritis Treatment After Positive Phase III Results

EXTON, PA, Oct. 10, 2024 (GLOBE NEWSWIRE) -- While GSK’s Benlysta (belimumab) and Aurinia’s Lupkynis (voclosporin) have been important advances in the treatment arsenal for lupus nephritis (LN), a...
October 13, 2023 05:40 ET | Source: UXUY

UXUY Implements Bitcoin Lightning Node to Serve Multi-Chain Trading for Taproot Assets

Singapore, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Today 13th of October, 2023, the next-generation decentralized trading platform UXUY will officially implement the Bitcoin Lightning Network node named...
February 26, 2019 16:07 ET | Source: Equillium

Equillium Announces Plan to Develop EQ001 for the Treatment of Lupus Nephritis

Clinical trial evaluating EQ001 for the treatment of refractory lupus nephritis to commence in 2H 2019 Ongoing EQ001 development programs in acute graft-versus-host disease and severe asthma remain...